Value of Macrophage-Colony Stimulating Factor as a New Marker of Bone Lesions in Multiple Myeloma
The Primary objective of this study is to compare serum levels of Macrophage-Colony Stimulating Factor (M-CSF) in a population of patients with multiple myeloma (MM), in a population of patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) and in a control population.
Multiple Myeloma
BIOLOGICAL: blood samples|BIOLOGICAL: Bone marow samples
Serum Macrophage-Colony Stimulating Factor (M-CSF) levels, Day 1
Tumour osteolysis, determined by the presence of osteolytic lesions, osteopenia or pathological fractures, presence of bone pain, Day 1
The Primary objective of this study is to compare serum levels of Macrophage-Colony Stimulating Factor (M-CSF) in a population of patients with multiple myeloma (MM), in a population of patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) and in a control population.